Cardiovascular clinical research

Researchers

  • Alba Oliveras

    Cardiovascular clinical research

  • Anna Contra Carne

    Cardiovascular clinical research

  • Antonio Carol Ruiz

    Cardiovascular clinical research

  • Antonia Ortega Díaz

    Cardiovascular clinical research

  • Carlos Enrique Sabbagh Fajardo

    Cardiovascular clinical research

  • carmen martin

    Cardiovascular clinical research

  • Elizabeth Mena Sebastià

    Cardiovascular clinical research

  • Joan Pol Monteys Montblanch

    Cardiovascular clinical research

  • José Navarrete Monte

    Cardiovascular clinical research

  • Maria Del Señor Cortés Fernández

    Cardiovascular clinical research

  • Marta Camprecios Crespo

    Cardiovascular clinical research

  • Mercè Faraudo

    Cardiovascular clinical research

  • Miriam Garcia Bermudez

    Cardiovascular clinical research

  • Olga Guri

    Cardiovascular clinical research

  • Peter Castellanos

    Cardiovascular clinical research

  • Pilar Sánchez Chamero

    Cardiovascular clinical research

    Phd
  • Raúl Lafuente Masqueda

    Cardiovascular clinical research

  • Román Freixa Pamías

    Cardiovascular clinical research

    Phd
  • Sandra Lara Sanmartin

    Cardiovascular clinical research

Contact the group

Form
  • McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators. (Freixa R) 1148

    Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact

    Eur J Heart Fail. 2013;15(9):1062-73.
  • Ferreira S, Ortiz A, Germain DP, Viana M, Caldeira A, Camprecios M, Fenollar M, Gallegos Á, Garcia D, García-Robles JA, Egido J, Gutiérrez-Rivas E, Herrero JA, Mas S, Oancea R, Péres P, Salazar M, Solera J, Alves H, Garman SC, Oliveira JP. 1251

    The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.

    Mol Genet Metab. 2015;114(2):248-58.

Projects

    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Heart failure Events reduction with Remote Monitoring and eHealth Support Investigator Initiated Trial.

    • DISTRICT ATTORNEY:

      Dr. Josep Comín Colet. HUB

    • TYPE E:

      PIN-NO-EPA

    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Record of myocardial infarction without ST segment elevation.

    • DISTRICT ATTORNEY:

      European Society of Cardiology

    • TYPE E:

      PINE TREE

    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Non-interventional and transversal study to describe the management of NACO treatment in elderly patients with non-valvular atrial fibrillation (NAFV) in Spain. (RE-BELD studio).

    • DISTRICT ATTORNEY:

      Boehringer Ingelheim Spain

    • TYPE E:

      EPA-SP

    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Treatment with beta-blockers after myocardial infarction without reduced ejection fraction.

    • DISTRICT ATTORNEY:

      Carlos III National Cardiovascular Research Center (CNIC), Spain

    • TYPE E:

      RD2015

  • Cardiovascular clinical research

    Researcher
    • Year 2018
    • Sant Joan Despí Moisès Broggi Hospital

    Randomized comparison between invasive and conservative strategies in frail elderly patients with non-ST-segment elevation myocardial infarction (MOSCA-FRAIL),

    • DISTRICT ATTORNEY:

      Spanish Society of Cardiology

    • TYPE E:

      PI

  • Cardiovascular clinical research

    Researcher
    • Year 2018
    • Sant Joan Despí Moisès Broggi Hospital

    Risk factors associated with the progression of heart failure (HF) in patients with atrial fibrillation treated with a direct oral anticoagulant (rivaroxaban),

    • DISTRICT ATTORNEY:

      BAYER HISPANIA, SL,

    • TYPE E:

      EPA

  • Cardiovascular clinical research

    Researcher
    • Year 2018
    • Sant Joan Despí Moisès Broggi Hospital

    Randomized, parallel-group, placebo-controlled, double-blind, multicenter trial to evaluate the efficacy and safety of the oral GCs stimulator vericiguat in improving physical performance in daily activities in patients with heart failure and preserved ejection fraction,

    • DISTRICT ATTORNEY:

      Bayer AG

    • TYPE E:

      RD2015

  • Cardiovascular clinical research

    Researcher
    • Year 2018
    • Sant Joan Despí Moisès Broggi Hospital

    Confirm Rx™ Insertable Heart Monitor SMART Record

    • DISTRICT ATTORNEY:

      Abbott Medical Spain SA

    • TYPE E:

      EPA

  • Cardiovascular clinical research

    Researcher
    • Year 2018
    • Comprehensive Care Center Dos de Maig Hospital

    Prognostic determinants of mortality and readmission in patients with Advanced Heart Failure (HF) treated in Primary Care: HADES study,

    • DISTRICT ATTORNEY:

      Jordi Gol University Institute for Primary Care Research (IDIAP)

    • TYPE E:

      PI

  • Cardiovascular clinical research

    Researcher
    • Year 2018
    • Sant Joan Despí Moisès Broggi Hospital

    Study of satisfaction of the circuit prior to the programmed electrical cardioversion performed in a day hospital and of the impact of the information on the success of the procedure,

    • DISTRICT ATTORNEY:

      Mrs. Antonia Ortega Díaz

    • TYPE E:

      PI

Lines of action

  • Self control in carriers Mechanical prosthesis
  • Cryptogenetic stroke
  • Spontaneous coronary dissection
  • Atrial fibrillation, anticoagulation and stroke / bleeding
  • Integrated cardiology primary care
  • LDL control in post-SCA patients
  • Impact of IC Functional Unit on Hospital Admissions / Re-admissions

Documents

Information of interest

Links